Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Artificial Intelligence Drug R&D market size was valued at US$ 603.6 million in 2023. With growing demand in downstream market, the Artificial Intelligence Drug R&D is forecast to a readjusted size of US$ 1097.8 million by 2030 with a CAGR of 8.9% during review period.
The research report highlights the growth potential of the global Artificial Intelligence Drug R&D market. Artificial Intelligence Drug R&D are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence Drug R&D. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence Drug R&D market.
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Artificial Intelligence Drug R&D market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence Drug R&D market. It may include historical data, market segmentation by Type (e.g., AI Platfrom, Analytics Service), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence Drug R&D market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence Drug R&D market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence Drug R&D industry. This include advancements in Artificial Intelligence Drug R&D technology, Artificial Intelligence Drug R&D new entrants, Artificial Intelligence Drug R&D new investment, and other innovations that are shaping the future of Artificial Intelligence Drug R&D.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence Drug R&D market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence Drug R&D product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence Drug R&D market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence Drug R&D market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence Drug R&D market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence Drug R&D industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence Drug R&D market.
Market Segmentation:
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Artificial Intelligence Drug R&D market size was valued at US$ 603.6 million in 2023. With growing demand in downstream market, the Artificial Intelligence Drug R&D is forecast to a readjusted size of US$ 1097.8 million by 2030 with a CAGR of 8.9% during review period.
The research report highlights the growth potential of the global Artificial Intelligence Drug R&D market. Artificial Intelligence Drug R&D are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence Drug R&D. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence Drug R&D market.
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Artificial Intelligence Drug R&D market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence Drug R&D market. It may include historical data, market segmentation by Type (e.g., AI Platfrom, Analytics Service), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence Drug R&D market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence Drug R&D market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence Drug R&D industry. This include advancements in Artificial Intelligence Drug R&D technology, Artificial Intelligence Drug R&D new entrants, Artificial Intelligence Drug R&D new investment, and other innovations that are shaping the future of Artificial Intelligence Drug R&D.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence Drug R&D market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence Drug R&D product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence Drug R&D market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence Drug R&D market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence Drug R&D market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence Drug R&D industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence Drug R&D market.
Market Segmentation:
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- AI Platfrom
- Analytics Service
- Drug Discovery
- Precision Medicine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IBM Watson
- BioXel
- Insilico Medicine
- Gatehouse Bio
- Google DeepMind
- Genpact Cora
- Cyclica Inc
- QuantumBlack
- Nq Medical
- Phenomic AI
- Palantir Technologies
- BenevolentAI
- Atomwise
- Numerate
- Recursion Pharmaceuticals
- Exscientia
- TwoXAR
- AiCure
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size 2019-2030
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 AI Platfrom
2.2.2 Analytics Service
2.3 Artificial Intelligence Drug R&D Market Size by Type
2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Drug R&D Segment by Application
2.4.1 Drug Discovery
2.4.2 Precision Medicine
2.5 Artificial Intelligence Drug R&D Market Size by Application
2.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGIONS
4.1 Artificial Intelligence Drug R&D Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D by Country (2019-2024)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence Drug R&D Market Forecast
10.2.2 Canada Artificial Intelligence Drug R&D Market Forecast
10.2.3 Mexico Artificial Intelligence Drug R&D Market Forecast
10.2.4 Brazil Artificial Intelligence Drug R&D Market Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Artificial Intelligence Drug R&D Market Forecast
10.3.3 Korea Artificial Intelligence Drug R&D Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug R&D Market Forecast
10.3.5 India Artificial Intelligence Drug R&D Market Forecast
10.3.6 Australia Artificial Intelligence Drug R&D Market Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence Drug R&D Market Forecast
10.4.2 France Artificial Intelligence Drug R&D Market Forecast
10.4.3 UK Artificial Intelligence Drug R&D Market Forecast
10.4.4 Italy Artificial Intelligence Drug R&D Market Forecast
10.4.5 Russia Artificial Intelligence Drug R&D Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence Drug R&D Market Forecast
10.5.2 South Africa Artificial Intelligence Drug R&D Market Forecast
10.5.3 Israel Artificial Intelligence Drug R&D Market Forecast
10.5.4 Turkey Artificial Intelligence Drug R&D Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug R&D Market Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 IBM Watson
11.1.1 IBM Watson Company Information
11.1.2 IBM Watson Artificial Intelligence Drug R&D Product Offered
11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 IBM Watson Main Business Overview
11.1.5 IBM Watson Latest Developments
11.2 BioXel
11.2.1 BioXel Company Information
11.2.2 BioXel Artificial Intelligence Drug R&D Product Offered
11.2.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioXel Main Business Overview
11.2.5 BioXel Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Information
11.4.2 Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gatehouse Bio Main Business Overview
11.4.5 Gatehouse Bio Latest Developments
11.5 Google DeepMind
11.5.1 Google DeepMind Company Information
11.5.2 Google DeepMind Artificial Intelligence Drug R&D Product Offered
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Google DeepMind Main Business Overview
11.5.5 Google DeepMind Latest Developments
11.6 Genpact Cora
11.6.1 Genpact Cora Company Information
11.6.2 Genpact Cora Artificial Intelligence Drug R&D Product Offered
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genpact Cora Main Business Overview
11.6.5 Genpact Cora Latest Developments
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Information
11.7.2 Cyclica Inc Artificial Intelligence Drug R&D Product Offered
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cyclica Inc Main Business Overview
11.7.5 Cyclica Inc Latest Developments
11.8 QuantumBlack
11.8.1 QuantumBlack Company Information
11.8.2 QuantumBlack Artificial Intelligence Drug R&D Product Offered
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 QuantumBlack Main Business Overview
11.8.5 QuantumBlack Latest Developments
11.9 Nq Medical
11.9.1 Nq Medical Company Information
11.9.2 Nq Medical Artificial Intelligence Drug R&D Product Offered
11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nq Medical Main Business Overview
11.9.5 Nq Medical Latest Developments
11.10 Phenomic AI
11.10.1 Phenomic AI Company Information
11.10.2 Phenomic AI Artificial Intelligence Drug R&D Product Offered
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Phenomic AI Main Business Overview
11.10.5 Phenomic AI Latest Developments
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Information
11.11.2 Palantir Technologies Artificial Intelligence Drug R&D Product Offered
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Palantir Technologies Main Business Overview
11.11.5 Palantir Technologies Latest Developments
11.12 BenevolentAI
11.12.1 BenevolentAI Company Information
11.12.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
11.12.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BenevolentAI Main Business Overview
11.12.5 BenevolentAI Latest Developments
11.13 Atomwise
11.13.1 Atomwise Company Information
11.13.2 Atomwise Artificial Intelligence Drug R&D Product Offered
11.13.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Atomwise Main Business Overview
11.13.5 Atomwise Latest Developments
11.14 Numerate
11.14.1 Numerate Company Information
11.14.2 Numerate Artificial Intelligence Drug R&D Product Offered
11.14.3 Numerate Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Numerate Main Business Overview
11.14.5 Numerate Latest Developments
11.15 Recursion Pharmaceuticals
11.15.1 Recursion Pharmaceuticals Company Information
11.15.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
11.15.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Recursion Pharmaceuticals Main Business Overview
11.15.5 Recursion Pharmaceuticals Latest Developments
11.16 Exscientia
11.16.1 Exscientia Company Information
11.16.2 Exscientia Artificial Intelligence Drug R&D Product Offered
11.16.3 Exscientia Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Exscientia Main Business Overview
11.16.5 Exscientia Latest Developments
11.17 TwoXAR
11.17.1 TwoXAR Company Information
11.17.2 TwoXAR Artificial Intelligence Drug R&D Product Offered
11.17.3 TwoXAR Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 TwoXAR Main Business Overview
11.17.5 TwoXAR Latest Developments
11.18 AiCure
11.18.1 AiCure Company Information
11.18.2 AiCure Artificial Intelligence Drug R&D Product Offered
11.18.3 AiCure Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 AiCure Main Business Overview
11.18.5 AiCure Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size 2019-2030
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 AI Platfrom
2.2.2 Analytics Service
2.3 Artificial Intelligence Drug R&D Market Size by Type
2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Drug R&D Segment by Application
2.4.1 Drug Discovery
2.4.2 Precision Medicine
2.5 Artificial Intelligence Drug R&D Market Size by Application
2.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGIONS
4.1 Artificial Intelligence Drug R&D Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D by Country (2019-2024)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence Drug R&D Market Forecast
10.2.2 Canada Artificial Intelligence Drug R&D Market Forecast
10.2.3 Mexico Artificial Intelligence Drug R&D Market Forecast
10.2.4 Brazil Artificial Intelligence Drug R&D Market Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Artificial Intelligence Drug R&D Market Forecast
10.3.3 Korea Artificial Intelligence Drug R&D Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug R&D Market Forecast
10.3.5 India Artificial Intelligence Drug R&D Market Forecast
10.3.6 Australia Artificial Intelligence Drug R&D Market Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence Drug R&D Market Forecast
10.4.2 France Artificial Intelligence Drug R&D Market Forecast
10.4.3 UK Artificial Intelligence Drug R&D Market Forecast
10.4.4 Italy Artificial Intelligence Drug R&D Market Forecast
10.4.5 Russia Artificial Intelligence Drug R&D Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence Drug R&D Market Forecast
10.5.2 South Africa Artificial Intelligence Drug R&D Market Forecast
10.5.3 Israel Artificial Intelligence Drug R&D Market Forecast
10.5.4 Turkey Artificial Intelligence Drug R&D Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug R&D Market Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 IBM Watson
11.1.1 IBM Watson Company Information
11.1.2 IBM Watson Artificial Intelligence Drug R&D Product Offered
11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 IBM Watson Main Business Overview
11.1.5 IBM Watson Latest Developments
11.2 BioXel
11.2.1 BioXel Company Information
11.2.2 BioXel Artificial Intelligence Drug R&D Product Offered
11.2.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioXel Main Business Overview
11.2.5 BioXel Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Information
11.4.2 Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gatehouse Bio Main Business Overview
11.4.5 Gatehouse Bio Latest Developments
11.5 Google DeepMind
11.5.1 Google DeepMind Company Information
11.5.2 Google DeepMind Artificial Intelligence Drug R&D Product Offered
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Google DeepMind Main Business Overview
11.5.5 Google DeepMind Latest Developments
11.6 Genpact Cora
11.6.1 Genpact Cora Company Information
11.6.2 Genpact Cora Artificial Intelligence Drug R&D Product Offered
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genpact Cora Main Business Overview
11.6.5 Genpact Cora Latest Developments
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Information
11.7.2 Cyclica Inc Artificial Intelligence Drug R&D Product Offered
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cyclica Inc Main Business Overview
11.7.5 Cyclica Inc Latest Developments
11.8 QuantumBlack
11.8.1 QuantumBlack Company Information
11.8.2 QuantumBlack Artificial Intelligence Drug R&D Product Offered
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 QuantumBlack Main Business Overview
11.8.5 QuantumBlack Latest Developments
11.9 Nq Medical
11.9.1 Nq Medical Company Information
11.9.2 Nq Medical Artificial Intelligence Drug R&D Product Offered
11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nq Medical Main Business Overview
11.9.5 Nq Medical Latest Developments
11.10 Phenomic AI
11.10.1 Phenomic AI Company Information
11.10.2 Phenomic AI Artificial Intelligence Drug R&D Product Offered
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Phenomic AI Main Business Overview
11.10.5 Phenomic AI Latest Developments
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Information
11.11.2 Palantir Technologies Artificial Intelligence Drug R&D Product Offered
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Palantir Technologies Main Business Overview
11.11.5 Palantir Technologies Latest Developments
11.12 BenevolentAI
11.12.1 BenevolentAI Company Information
11.12.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
11.12.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BenevolentAI Main Business Overview
11.12.5 BenevolentAI Latest Developments
11.13 Atomwise
11.13.1 Atomwise Company Information
11.13.2 Atomwise Artificial Intelligence Drug R&D Product Offered
11.13.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Atomwise Main Business Overview
11.13.5 Atomwise Latest Developments
11.14 Numerate
11.14.1 Numerate Company Information
11.14.2 Numerate Artificial Intelligence Drug R&D Product Offered
11.14.3 Numerate Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Numerate Main Business Overview
11.14.5 Numerate Latest Developments
11.15 Recursion Pharmaceuticals
11.15.1 Recursion Pharmaceuticals Company Information
11.15.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
11.15.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Recursion Pharmaceuticals Main Business Overview
11.15.5 Recursion Pharmaceuticals Latest Developments
11.16 Exscientia
11.16.1 Exscientia Company Information
11.16.2 Exscientia Artificial Intelligence Drug R&D Product Offered
11.16.3 Exscientia Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Exscientia Main Business Overview
11.16.5 Exscientia Latest Developments
11.17 TwoXAR
11.17.1 TwoXAR Company Information
11.17.2 TwoXAR Artificial Intelligence Drug R&D Product Offered
11.17.3 TwoXAR Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 TwoXAR Main Business Overview
11.17.5 TwoXAR Latest Developments
11.18 AiCure
11.18.1 AiCure Company Information
11.18.2 AiCure Artificial Intelligence Drug R&D Product Offered
11.18.3 AiCure Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 AiCure Main Business Overview
11.18.5 AiCure Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of AI Platfrom
Table 3. Major Players of Analytics Service
Table 4. Artificial Intelligence Drug R&D Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 7. Artificial Intelligence Drug R&D Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 10. Global Artificial Intelligence Drug R&D Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2019-2024)
Table 12. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 13. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artificial Intelligence Drug R&D Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2019-2024)
Table 18. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2019-2024)
Table 22. Americas Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 24. Americas Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 26. APAC Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Table 28. APAC Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 30. APAC Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 32. Europe Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2019-2024)
Table 34. Europe Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 45. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 46. Key Industry Trends of Artificial Intelligence Drug R&D
Table 47. Global Artificial Intelligence Drug R&D Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. IBM Watson Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 52. IBM Watson Artificial Intelligence Drug R&D Product Offered
Table 53. IBM Watson Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. IBM Watson Main Business
Table 55. IBM Watson Latest Developments
Table 56. BioXel Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 57. BioXel Artificial Intelligence Drug R&D Product Offered
Table 58. BioXel Main Business
Table 59. BioXel Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. BioXel Latest Developments
Table 61. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 62. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 63. Insilico Medicine Main Business
Table 64. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Insilico Medicine Latest Developments
Table 66. Gatehouse Bio Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 67. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
Table 68. Gatehouse Bio Main Business
Table 69. Gatehouse Bio Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Gatehouse Bio Latest Developments
Table 71. Google DeepMind Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 72. Google DeepMind Artificial Intelligence Drug R&D Product Offered
Table 73. Google DeepMind Main Business
Table 74. Google DeepMind Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Google DeepMind Latest Developments
Table 76. Genpact Cora Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 77. Genpact Cora Artificial Intelligence Drug R&D Product Offered
Table 78. Genpact Cora Main Business
Table 79. Genpact Cora Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Genpact Cora Latest Developments
Table 81. Cyclica Inc Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 82. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
Table 83. Cyclica Inc Main Business
Table 84. Cyclica Inc Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Cyclica Inc Latest Developments
Table 86. QuantumBlack Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 87. QuantumBlack Artificial Intelligence Drug R&D Product Offered
Table 88. QuantumBlack Main Business
Table 89. QuantumBlack Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. QuantumBlack Latest Developments
Table 91. Nq Medical Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 92. Nq Medical Artificial Intelligence Drug R&D Product Offered
Table 93. Nq Medical Main Business
Table 94. Nq Medical Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Nq Medical Latest Developments
Table 96. Phenomic AI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 97. Phenomic AI Artificial Intelligence Drug R&D Product Offered
Table 98. Phenomic AI Main Business
Table 99. Phenomic AI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Phenomic AI Latest Developments
Table 101. Palantir Technologies Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 102. Palantir Technologies Artificial Intelligence Drug R&D Product Offered
Table 103. Palantir Technologies Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Palantir Technologies Main Business
Table 105. Palantir Technologies Latest Developments
Table 106. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 107. BenevolentAI Artificial Intelligence Drug R&D Product Offered
Table 108. BenevolentAI Main Business
Table 109. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. BenevolentAI Latest Developments
Table 111. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 112. Atomwise Artificial Intelligence Drug R&D Product Offered
Table 113. Atomwise Main Business
Table 114. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Atomwise Latest Developments
Table 116. Numerate Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 117. Numerate Artificial Intelligence Drug R&D Product Offered
Table 118. Numerate Main Business
Table 119. Numerate Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Numerate Latest Developments
Table 121. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 122. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
Table 123. Recursion Pharmaceuticals Main Business
Table 124. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Recursion Pharmaceuticals Latest Developments
Table 126. Exscientia Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 127. Exscientia Artificial Intelligence Drug R&D Product Offered
Table 128. Exscientia Main Business
Table 129. Exscientia Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Exscientia Latest Developments
Table 131. TwoXAR Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 132. TwoXAR Artificial Intelligence Drug R&D Product Offered
Table 133. TwoXAR Main Business
Table 134. TwoXAR Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. TwoXAR Latest Developments
Table 136. AiCure Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 137. AiCure Artificial Intelligence Drug R&D Product Offered
Table 138. AiCure Main Business
Table 139. AiCure Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. AiCure Latest Developments
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of AI Platfrom
Table 3. Major Players of Analytics Service
Table 4. Artificial Intelligence Drug R&D Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 7. Artificial Intelligence Drug R&D Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 10. Global Artificial Intelligence Drug R&D Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2019-2024)
Table 12. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 13. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artificial Intelligence Drug R&D Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2019-2024)
Table 18. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2019-2024)
Table 22. Americas Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 24. Americas Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 26. APAC Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Table 28. APAC Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 30. APAC Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 32. Europe Artificial Intelligence Drug R&D Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2019-2024)
Table 34. Europe Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 45. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 46. Key Industry Trends of Artificial Intelligence Drug R&D
Table 47. Global Artificial Intelligence Drug R&D Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. IBM Watson Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 52. IBM Watson Artificial Intelligence Drug R&D Product Offered
Table 53. IBM Watson Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. IBM Watson Main Business
Table 55. IBM Watson Latest Developments
Table 56. BioXel Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 57. BioXel Artificial Intelligence Drug R&D Product Offered
Table 58. BioXel Main Business
Table 59. BioXel Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. BioXel Latest Developments
Table 61. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 62. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 63. Insilico Medicine Main Business
Table 64. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Insilico Medicine Latest Developments
Table 66. Gatehouse Bio Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 67. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
Table 68. Gatehouse Bio Main Business
Table 69. Gatehouse Bio Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Gatehouse Bio Latest Developments
Table 71. Google DeepMind Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 72. Google DeepMind Artificial Intelligence Drug R&D Product Offered
Table 73. Google DeepMind Main Business
Table 74. Google DeepMind Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Google DeepMind Latest Developments
Table 76. Genpact Cora Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 77. Genpact Cora Artificial Intelligence Drug R&D Product Offered
Table 78. Genpact Cora Main Business
Table 79. Genpact Cora Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Genpact Cora Latest Developments
Table 81. Cyclica Inc Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 82. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
Table 83. Cyclica Inc Main Business
Table 84. Cyclica Inc Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Cyclica Inc Latest Developments
Table 86. QuantumBlack Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 87. QuantumBlack Artificial Intelligence Drug R&D Product Offered
Table 88. QuantumBlack Main Business
Table 89. QuantumBlack Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. QuantumBlack Latest Developments
Table 91. Nq Medical Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 92. Nq Medical Artificial Intelligence Drug R&D Product Offered
Table 93. Nq Medical Main Business
Table 94. Nq Medical Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Nq Medical Latest Developments
Table 96. Phenomic AI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 97. Phenomic AI Artificial Intelligence Drug R&D Product Offered
Table 98. Phenomic AI Main Business
Table 99. Phenomic AI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Phenomic AI Latest Developments
Table 101. Palantir Technologies Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 102. Palantir Technologies Artificial Intelligence Drug R&D Product Offered
Table 103. Palantir Technologies Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Palantir Technologies Main Business
Table 105. Palantir Technologies Latest Developments
Table 106. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 107. BenevolentAI Artificial Intelligence Drug R&D Product Offered
Table 108. BenevolentAI Main Business
Table 109. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. BenevolentAI Latest Developments
Table 111. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 112. Atomwise Artificial Intelligence Drug R&D Product Offered
Table 113. Atomwise Main Business
Table 114. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Atomwise Latest Developments
Table 116. Numerate Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 117. Numerate Artificial Intelligence Drug R&D Product Offered
Table 118. Numerate Main Business
Table 119. Numerate Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Numerate Latest Developments
Table 121. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 122. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
Table 123. Recursion Pharmaceuticals Main Business
Table 124. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Recursion Pharmaceuticals Latest Developments
Table 126. Exscientia Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 127. Exscientia Artificial Intelligence Drug R&D Product Offered
Table 128. Exscientia Main Business
Table 129. Exscientia Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Exscientia Latest Developments
Table 131. TwoXAR Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 132. TwoXAR Artificial Intelligence Drug R&D Product Offered
Table 133. TwoXAR Main Business
Table 134. TwoXAR Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. TwoXAR Latest Developments
Table 136. AiCure Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 137. AiCure Artificial Intelligence Drug R&D Product Offered
Table 138. AiCure Main Business
Table 139. AiCure Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. AiCure Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2023)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2023
Figure 10. Artificial Intelligence Drug R&D in Drug Discovery
Figure 11. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2019-2024) & ($ Millions)
Figure 12. Artificial Intelligence Drug R&D in Precision Medicine
Figure 13. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2019-2024) & ($ Millions)
Figure 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2023
Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2023
Figure 16. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 18. APAC Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 19. Europe Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 21. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2023
Figure 22. United States Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2023
Figure 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type in 2023
Figure 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application in 2023
Figure 29. China Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2023
Figure 36. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Figure 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Figure 38. Germany Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 52. APAC Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 53. Europe Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 55. United States Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 56. Canada Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 59. China Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 60. Japan Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 61. Korea Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 63. India Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 64. Australia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 65. Germany Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 66. France Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 67. UK Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 68. Italy Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 69. Russia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 70. Spain Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 73. Israel Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 76. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2023)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2023
Figure 10. Artificial Intelligence Drug R&D in Drug Discovery
Figure 11. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2019-2024) & ($ Millions)
Figure 12. Artificial Intelligence Drug R&D in Precision Medicine
Figure 13. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2019-2024) & ($ Millions)
Figure 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2023
Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2023
Figure 16. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 18. APAC Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 19. Europe Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2019-2024 ($ Millions)
Figure 21. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2023
Figure 22. United States Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2023
Figure 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type in 2023
Figure 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application in 2023
Figure 29. China Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2023
Figure 36. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Figure 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Figure 38. Germany Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Artificial Intelligence Drug R&D Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 52. APAC Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 53. Europe Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 55. United States Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 56. Canada Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 59. China Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 60. Japan Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 61. Korea Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 63. India Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 64. Australia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 65. Germany Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 66. France Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 67. UK Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 68. Italy Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 69. Russia Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 70. Spain Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 73. Israel Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Artificial Intelligence Drug R&D Market Size 2025-2030 ($ Millions)
Figure 76. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2025-2030)
